Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction

被引:13
作者
Mlecnik, Bernhard [1 ,2 ]
Sanchez-Cabo, Fatima [2 ,3 ]
Charoentong, Pornpimol [2 ]
Bindea, Gabriela [1 ,2 ]
Pages, Franck [1 ,4 ]
Berger, Anne [4 ]
Galon, Jerome [1 ,4 ]
Trajanoski, Zlatko [2 ]
机构
[1] INSERM, U872, Paris, France
[2] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria
[3] Spanish Natl Ctr Cardiovasc Res, Genom Unit, Madrid, Spain
[4] Georges Pompidou European Hosp, AP HP, Paris, France
基金
奥地利科学基金会;
关键词
LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CYTOSCAPE PLUG-IN; COLORECTAL-CANCER; GENE ONTOLOGY; OPTIMAL CUTPOINT; NETWORKS; MODELS; GROWTH; MEMORY; PROLIFERATION;
D O I
10.1186/1471-2164-11-S1-S7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Cancer progression is a complex process involving host-tumor interactions by multiple molecular and cellular factors of the tumor microenvironment. Tumor cells that challenge immune activity may be vulnerable to immune destruction. To address this question we have directed major efforts towards data integration and developed and installed a database for cancer immunology with more than 1700 patients and associated clinical data and biomolecular data. Mining of the database revealed novel insights into the molecular mechanisms of tumor-immune cell interaction. In this paper we present the computational tools used to analyze integrated clinical and biomolecular data. Specifically, we describe a database for heterogenous data types, the interfacing bioinformatics and statistical tools including clustering methods, survival analysis, as well as visualization methods. Additionally, we discuss generic issues relevant to the integration of clinical and biomolecular data, as well as recent developments in integrative data analyses including biomolecular network reconstruction and mathematical modeling.
引用
收藏
页数:7
相关论文
共 43 条
[1]
Statistics notes - The cost of dichotomising continuous variables [J].
Altman, DG ;
Royston, P .
BRITISH MEDICAL JOURNAL, 2006, 332 (7549) :1080-1080
[2]
DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[3]
ANDERSON ACM, SINGLE CELL BASED MO
[4]
Integrative mathematical oncology [J].
Anderson, Alexander R. A. ;
Quaranta, Vito .
NATURE REVIEWS CANCER, 2008, 8 (03) :227-234
[5]
The role of models in understanding CD8+ T-cell memory [J].
Antia, R ;
Ganusov, VV ;
Ahmed, R .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (02) :101-111
[6]
A history of the study of solid tumour growth: The contribution of mathematical modelling [J].
Araujo, RP ;
McElwain, DLS .
BULLETIN OF MATHEMATICAL BIOLOGY, 2004, 66 (05) :1039-1091
[7]
Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[8]
Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies [J].
Atreya, Imke ;
Neurath, Markus F. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) :561-572
[9]
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer [J].
Benson, AB ;
Schrag, D ;
Somerfield, MR ;
Cohen, AM ;
Figueredo, AT ;
Flynn, PJ ;
Krzyzanowska, MK ;
Maroun, J ;
McAllister, P ;
Van Cutsem, E ;
Brouwers, M ;
Charette, M ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3408-3419
[10]
Primer: making sense of T-cell memory [J].
Beverley, Peter C. L. .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (01) :43-49